| ID | 1489 |
|---|
| No | 1489 |
|---|
| Brand Name | GABICA CAPSULES 150 MG |
|---|
| Ingredients | PREGABALIN 150 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | ALU-ALU |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 2 X 7'S AND 5 X 7'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | THE MANAGEMENT OF NEUROPATHIC ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY , POSTHERPETIC NEURALGIA, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION. FOR TREATMENT OF GENERALIZED ANXIETY DISORDER IN ADULTS. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | HARD GELATIN CAPSULE WITH DARK BLUE OPAQUE CAP AND YELLOW OPAQUE BODY PRINTED 150 MG AND GETZ LOGO IN BLACK,CONTAINING WHITE POWDER. |
|---|
| Note | |
|---|
| License Owner | LAO INTER PHARMA CO.,LTD |
|---|
| Manufacturer | GETZ PHARMA (PRIVATE) LIMITED |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 I 3577/11 |
|---|
| FDD Registration Date | 10/02/2023 |
|---|
| Expiry Date | 09/02/2026 |
|---|
